From: Periodical assessment of genitourinary and gastrointestinal toxicity in patients who underwent prostate low-dose-rate brachytherapy
Grade 0
Grade 1
Grade 2
Grade 3
GU (acute)
48 (22.0)
157 (72.0)
10 (4.6)
3 (1.4)
GU (late)
79 (36.2)
112 (51.4)
25 (11.5)
2 (0.9)
GI (acute)
201 (92.2)
16 (7.3)
1 (0.5)
0
GI (late)
172 (78.9)
40 (18.3)
6 (2.8)
NCI-CTCAE (ver. 3.0)
(%)